Document Detail

Coronary artery perfusion and myocardial performance after patent ductus arteriosus ligation.
MedLine Citation:
PMID:  22153859     Owner:  NLM     Status:  Publisher    
OBJECTIVES: To study coronary artery (CA) perfusion and myocardial performance after patent ductus arteriosus (PDA) ligation. The postoperative course in premature infants undergoing surgical ligation of PDA is often complicated by cardiorespiratory instability secondary to impaired left ventricular performance. METHODS: Serial echocardiography was performed before and after (1, 8, and 24 hours) PDA ligation to assess systolic (left ventricular output [LVO]) and diastolic (isovolumic relaxation time, E and A wave peak velocity) myocardial performance, and CA diastolic flow (CA velocity time integral and flow). The ratio of CA flow to LVO was calculated as a surrogate of coronary flow. RESULTS: A total of 20 infants (gestational age at birth, 26.3 ± 0.7 weeks) requiring PDA ligation at a median of 28.5 days (range, 9-40) after birth and weight of 780 g (range, 570-2840) were studied. A postoperative increase in the CA flow/LVO ratio was demonstrated. An early decrease in E and A wave peak velocity (P < .05) and increase in isovolumic relaxation time (P < .05) were demonstrated at 1 hour, before any clinical deterioration. A low baseline CA velocity time integral was associated with a low E/A ratio (r = 0.63, P = .01) at 1 hour and lower systolic blood pressure at 8 hours (r = 0.5, P = .05). The postoperative need for inotropes (n = 8) was associated with a low baseline CA velocity time integral at 1 hour (r = 0.52, P < .05), low LVO at 1 and 8 hours (P < .05), and increased oxygen requirement at 24 hours (P < .05). CONCLUSIONS: PDA ligation is followed by altered CA perfusion. Perioperative evaluation of the CA perfusion can help identify neonates at risk of impaired myocardial performance, systolic hypotension, and the need for inotropes.
Arvind Sehgal; Patrick J McNamara
Related Documents :
6324709 - Myocardial infarction and severe thromboembolic complications. as seen in an estrogen-d...
18657679 - Platelet inhibitor therapy: current perspectives and emerging novel agents: introduction.
8043909 - Thrombinogenesis and its pharmacological modulation in atherosclerosis.
16401379 - Appropriate invasive and conservative treatment approaches for patients with st-elevati...
8578489 - Clinical trials of primary and secondary prevention of thrombosis and restenosis.
16918379 - Antithrombotic therapy.
2950749 - Role of nuclear cardiology in evaluating the total ischemic burden in coronary artery d...
8724569 - Mr imaging of congenital heart disease.
2931999 - Decreased auxotonic sarcomere shortening in hypertrophied rabbit myocardium.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-6
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  -     ISSN:  1097-685X     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.
Monash Newborn, Monash Medical Centre, Victoria, Australia; Monash University, Victoria, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The universal bed model for patient care improves outcome and lowers cost in cardiac surgery.
Next Document:  Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutarald...